Literature DB >> 18838805

Isolation and characterization of a novel equol-producing bacterium from human feces.

Shin-ichiro Yokoyama1, Tohru Suzuki.   

Abstract

An equol-producing bacterium was newly isolated from the feces of healthy humans and its morphological and biochemical properties were characterized. The cells were obligate anaerobes. They were non-sporulating, non-motile, gram-positive bacilliform bacteria with a pleomorphic morphology. The strain was catalase-positive, and oxidase-, urease-, and indole-negative. The only other sugar utilized by the strain was glycerin. The strain also degraded gelatin, but not esculin. It was most closely related to Eggerthella hongkongensis HKU10, with 93.3% 16S rDNA nucleotide sequence homology. Based on these features, the isolate was identified as a novel species of the genus Eggerthella. It was named Eggerthella sp. YY7918. Strain YY7918 converted substrates daidzein and dihydrodaidzein into S-equol, but did not convert daidzin, glysitein, genistein, or formononetin into it. An antimicrobial susceptibility assay indicated that strain YY7918 was susceptible to aminoglycoside-, tetracycline-, and new quinolone-antibiotics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18838805     DOI: 10.1271/bbb.80329

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  36 in total

Review 1.  Equol: history, chemistry, and formation.

Authors:  Kenneth D R Setchell; Carlo Clerici
Journal:  J Nutr       Date:  2010-06-02       Impact factor: 4.798

2.  Complete genomic sequence of the O-desmethylangolensin-producing bacterium Clostridium rRNA cluster XIVa strain SY8519, isolated from adult human intestine.

Authors:  Shin-ichiro Yokoyama; Kenshiro Oshima; Izumi Nomura; Masahira Hattori; Tohru Suzuki
Journal:  J Bacteriol       Date:  2011-10       Impact factor: 3.490

Review 3.  Does equol production determine soy endocrine effects?

Authors:  Dana Shor; Thozhukat Sathyapalan; Stephen L Atkin; Natalie J Thatcher
Journal:  Eur J Nutr       Date:  2012-02-25       Impact factor: 5.614

Review 4.  The first 1000 cultured species of the human gastrointestinal microbiota.

Authors:  Mirjana Rajilić-Stojanović; Willem M de Vos
Journal:  FEMS Microbiol Rev       Date:  2014-06-27       Impact factor: 16.408

Review 5.  The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?

Authors:  M Andrea Azcárate-Peril; Michael Sikes; José M Bruno-Bárcena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-23       Impact factor: 4.052

Review 6.  The Interactions between Polyphenols and Microorganisms, Especially Gut Microbiota.

Authors:  Małgorzata Makarewicz; Iwona Drożdż; Tomasz Tarko; Aleksandra Duda-Chodak
Journal:  Antioxidants (Basel)       Date:  2021-01-28

7.  Complete genomic sequence of the equol-producing bacterium Eggerthella sp. strain YY7918, isolated from adult human intestine.

Authors:  Shin-ichiro Yokoyama; Kenshiro Oshima; Izumi Nomura; Masahira Hattori; Tohru Suzuki
Journal:  J Bacteriol       Date:  2011-10       Impact factor: 3.490

Review 8.  Bacterial species involved in the conversion of dietary flavonoids in the human gut.

Authors:  Annett Braune; Michael Blaut
Journal:  Gut Microbes       Date:  2016-03-10

9.  S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.

Authors:  Mandeep K Virk-Baker; Stephen Barnes; Helen Krontiras; Tim R Nagy
Journal:  Nutr Res       Date:  2013-12-18       Impact factor: 3.315

10.  Relationship of serum levels and dietary intake of isoflavone, and the novel bacterium Slackia sp. strain NATTS with the risk of prostate cancer: a case-control study among Japanese men.

Authors:  Yoshie Nagata; Yukiko Sugiyama; Fumimasa Fukuta; Akio Takayanagi; Naoya Masumori; Taiji Tsukamoto; Hiroshi Akasaka; Hirofumi Ohnishi; Shigeyuki Saitoh; Tetsuji Miura; Kaoru Moriyama; Hirokazu Tsuji; Hideyuki Akaza; Mitsuru Mori
Journal:  Int Urol Nephrol       Date:  2016-06-04       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.